ACW | Small Caps

Actinogen Medical ASX ACW cognitive improvement Xanamem XanaHES Alzheimer’s disease neurological

Actinogen Medical announces ‘breakthrough’ study results for Alzheimer’s drug Xanamem

October 1, 2019

Actinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safety study first initiated last year. The results reaffirm the foundational hypothesis that reducing...

Read more

Actinogen Medical ASX ACW Phase 2 Alzheimer's disease trial results fail dementia

Actinogen Medical phase two Alzheimer’s clinical trial disappoints

May 7, 2019

Biotech company Actinogen Medical (ASX: ACW) has reported a mixed bag of results including some disappointing outcomes from its XanADu phase two clinical trial treating patients with mild dementia due...

Read more

Actinogen Medical ASX ACW US biotech investor Alzheimer’s XanADu study

Actinogen Medical attracts US biotech investor as Alzheimer’s XanADu study remains on track

May 23, 2018

Actinogen Medical (ASX: ACW) has received a double-shot of positive news earlier today after the biotech company received the all-clear from the Data Safety and Monitoring Board (DSMB) to continue its...

Read more

Actinogen Medical ASX ACW XanADu treat Alzheimer’s disease

Actinogen moves towards XanADu starting line to treat Alzheimer’s disease

March 21, 2018

Biotech company Actinogen Medical (ASX: ACW) has confirmed that it has obtained half of the required patients in order to conduct its landmark Phase 2 clinical trial of Xanamem, a drug candidate to tr...

Read more

RECENT POSTS

Maggie Beer Maggie’s Food for Life ASX MBH plant based prepared meals

Maggie Beer launches plant-based meals in Coles stores

August 5, 2020

Poseidon Nickel ASX POS massive sulphide intersection Golden Swan nickel target

Poseidon Nickel hits second massive sulphide intersection at Golden Swan nickel target

August 5, 2020

Navarre Minerals ASX NML Resolution Lode gold drilling COVID-19

Navarre Minerals drilling programs continue during Victoria’s COVID-19 lockdown

August 5, 2020

Animoca Brands Atari blockchain classic games

Animoca Brands and Atari expand strategic partnership to introduce blockchain gaming to the masses

August 5, 2020

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

Stage four Australian tax office ATO super withdrawals

Stage four but tax office will move against super withdrawals

August 4, 2020

US slump smashes Aussie stocks ASX July 2020

Weekly review: big US slump smashes Aussie stocks lower

August 1, 2020

Property market fall Australia COVID-19 2020

Property market primed to fall – but by how much?

July 31, 2020

TRENDING POSTS

Stage four Australian tax office ATO super withdrawals

Stage four but tax office will move against super withdrawals

Kingsgate Consolidation ASX KCN TAFTA lawsuit closure Chatree gold mine Thailand

Kingsgate wins multi-million dollar claim over closure of its Chatree gold mine in Thailand

Shree Minerals ASX SHH Lachlan Fold Belt gold tenement

Shree Minerals’ gold hunt now leads to the Lachlan Fold Belt

Kate Vale ASX ESH Google YouTube Spotify managing director Esports Mogul Board

Mogul recruits former Google, YouTube and Spotify managing director to fortify its growth in emerging eSports industry

Investigator Resources ASX IVR silver price Paris project

Investigator Resources positions to offer leveraging to the silver price

Piedmont Lithium hydroxide producer ASX NASDAQ PLL lithium-ion battery electric vehicle markets

Piedmont Lithium accelerates towards becoming a global lithium hydroxide producer

MSL Solutions Openpay golf ASX OPY

MSL Solutions partners with Openpay in exclusive three-year deal

Kalamazoo Resources ASX KZR Ashburton Gold Project exploration team

Kalamazoo Resources adds well-credentialed geologists to Ashburton development team

Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.